Implications for implementation and adoption of telehealth in developing countries: a systematic review of China’s practices and experiences.

Implications for implementation and adoption of telehealth in developing countries: a systematic review of China’s practices and experiences.

Publication date: Sep 18, 2023

The rapid advancement of telehealth technologies has the potential to revolutionize healthcare delivery, especially in developing countries and resource-limited settings. Telehealth played a vital role during the COVID-19 pandemic, supporting numerous healthcare services. We conducted a systematic review to gain insights into the characteristics, barriers, and successful experiences in implementing telehealth during the COVID-19 pandemic in China, a representative of the developing countries. We also provide insights for other developing countries that face similar challenges to developing and using telehealth during or after the pandemic. This systematic review was conducted through searching five prominent databases including PubMed/MEDLINE, Embase, Scopus, Cochrane Library, and Web of Science. We included studies clearly defining any use of telehealth services in all aspects of health care during the COVID-19 pandemic in China. We mapped the barriers, successful experiences, and recommendations based on the Consolidated Framework for Implementation Research (CFIR). A total of 32 studies met the inclusion criteria. Successfully implementing and adopting telehealth in China during the pandemic necessitates strategic planning across aspects at society level (increasing public awareness and devising appropriate insurance policies), organizational level (training health care professionals, improving workflows, and decentralizing tasks), and technological level (strategic technological infrastructure development and designing inclusive telehealth systems). WeChat, a widely used social networking platform, was the most common platform used for telehealth services. China’s practices in addressing the barriers may provide implications and evidence for other developing countries or low-and middle- income countries (LMICs) to implement and adopt telehealth systems.

Open Access PDF

Concepts Keywords
China Barriers
Healthcare China
Increasing Conducted
Pandemic Countries
Science Covid


Type Source Name
disease MESH COVID-19 pandemic
drug DRUGBANK Methionine
drug DRUGBANK Montelukast
disease VO effective
disease IDO country
disease VO population
drug DRUGBANK Trestolone
disease IDO quality
disease VO USA
drug DRUGBANK Coenzyme M
disease VO protocol
disease IDO intervention
disease VO effectiveness
drug DRUGBANK Pentaerythritol tetranitrate
disease IDO process
drug DRUGBANK Spinosad
disease MESH complications
disease MESH retirement
disease VO Gap
drug DRUGBANK Etoperidone
disease VO time
disease VO device
disease VO storage
disease IDO blood
disease MESH Emergency
disease MESH hospital infections
disease MESH burnout
disease VO viability
disease VO organization
disease VO pregnant women
disease MESH Morbidity
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Carboxyamidotriazole
disease MESH chronic pain
disease MESH Diabetic Retinopathy
disease MESH psychiatric disorders
disease MESH multiple organ dysfunction syndrome
disease MESH Hypertension
drug DRUGBANK Guanosine
drug DRUGBANK Bismuth subgallate
disease VO vaccination
disease MESH autism
disease MESH critically ill
disease MESH myocardial infarction
drug DRUGBANK Isosorbide Mononitrate
disease MESH movement disorders
disease MESH Psychological Trauma
disease VO Canada
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)